Your browser doesn't support javascript.
Demographic and Clinical Factors Associated with Reactivity of Anti-SARS-CoV-2 Antibodies in Serbian Convalescent Plasma Donors.
Grujic, Jasmina; Bujandric, Nevenka; Budakov-Obradovic, Zorana; Dolinaj, Vladimir; Bogdan, Damir; Savic, Nebojsa; Cabezas-Cruz, Alejandro; Mijatovic, Dragana; Simin, Verica; Andelic, Nikola; Banovic, Pavle.
  • Grujic J; Blood Transfusion Institute Vojvodina, 21000 Novi Sad, Serbia.
  • Bujandric N; Faculty of Medicine in Novi Sad, University of Novi Sad, 21000 Novi Sad, Serbia.
  • Budakov-Obradovic Z; Blood Transfusion Institute Vojvodina, 21000 Novi Sad, Serbia.
  • Dolinaj V; Faculty of Medicine in Novi Sad, University of Novi Sad, 21000 Novi Sad, Serbia.
  • Bogdan D; Blood Transfusion Institute Vojvodina, 21000 Novi Sad, Serbia.
  • Savic N; Faculty of Medicine in Novi Sad, University of Novi Sad, 21000 Novi Sad, Serbia.
  • Cabezas-Cruz A; Faculty of Medicine in Novi Sad, University of Novi Sad, 21000 Novi Sad, Serbia.
  • Mijatovic D; Department of Anesthesia and Intensive Care, Clinical Centre of Vojvodina, 21000 Novi Sad, Serbia.
  • Simin V; Social Sciences and Computing, University of Belgrade, 11000 Belgrade, Serbia.
  • Andelic N; Transfusion Medicine Department, Clinic for Vascular and Endovascular Surgery, Clinical Centre of Serbia, 11000 Belgrade, Serbia.
  • Banovic P; Anses, INRAE, Ecole Nationale Vétérinaire d'Alfort, UMR BIPAR, Laboratoire de Santé Animale, F-94700 Maisons-Alfort, France.
Int J Environ Res Public Health ; 19(1)2021 Dec 21.
Article in English | MEDLINE | ID: covidwho-1580858
ABSTRACT
Passive immunotherapy with convalescent COVID-19 plasma (CCP) is used as a therapeutic procedure in many countries, including Serbia. In this study, we analyzed the association between demographic factors, COVID-19 severity and the reactivity of anti-SARS-CoV-2 antibodies (Abs) in Serbian CCP donors. Individuals (n = 468) recovered from confirmed SARS-CoV-2 infection, and who were willing to donate their plasma for passive immunization of COVID-19 patients were enrolled in the study. Plasma samples were tested for the presence of IgG reactive to SARS-CoV-2 spike glycoprotein (S1) and nucleocapsid antigens. Individuals were characterized according to age, gender, comorbidities, COVID-19 severity, ABO blood type and RhD factor. Total of 420 candidates (420/468; 89.74%) reached the levels of anti-SARS-CoV-2 IgG that qualified them for inclusion in CCP donation program. Further statistical analysis showed that male individuals (p = 0.034), older age groups (p < 0.001), existence of hypertension (p = 0.008), and severe COVID-19 (p = 0.000) are linked with higher levels of anti-SARS-CoV-2 Abs. These findings will guide the selection of CCP donors in Serbia. Further studies need to be conducted to assess the neutralization potency and clinical efficiency of CCP collected from Serbian donors with high anti-SARS-CoV-2 IgG reactivity.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Qualitative research / Randomized controlled trials Limits: Aged / Humans / Male Language: English Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Qualitative research / Randomized controlled trials Limits: Aged / Humans / Male Language: English Year: 2021 Document Type: Article